CODX vs MA
Co-Diagnostics, Inc. Common Stock (CODX) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
CODX currently screens at market cap $31.4M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the CODX and MA stock pages for the full models.
Not investment advice.